Rare Tumors of Ovary: Case Report and Literature Review

DOI: 10.4236/ojpathology.2012.23015   PDF   HTML   XML   4,431 Downloads   7,753 Views   Citations

Abstract

Introduction: Large cell neuroendocrine carcinoma (LCNEC) or non small cell neuroendocrine carcinoma the ovary is a rare entity and is frequently associated with ovarian surface epithelial tumors. However, its association with serous carcinoma is rarer, in our knowledge tree cases has been described in international literature and the first case in Moroccan literature. Case Report: A 54-year-old woman presented with a pelvic mass measuring 15 cm in diameter. She underwent an exploratory laparotomy with resection of the pelvic mass. Diffuse and nodular intra-abdominal disseminations were observed. Immunohistochemistry stain confirmed the diagnosis of large cell neuroendocrine carcinoma with serous carcinoma. The patient received three courses of carboplatin and paclitaxel and she's still alivewith a decline of 6 months. Its clinicopathologic association is discussed and the literature is reviewed. Conclusion: In summary, ovarian LCNEC is an aggressive tumor with a tendency to present at advanced stage and cause death within a mean of 17 months after diagnosis; however, some patients, particularly those with stage I disease and/or those who have received platinum-based therapy, may have a more favorable prognosis.

Share and Cite:

E. Fatemi Hinde, H. Nawal, S. Hannane, B. Sami, A. Afaf, B. Abdelaziz and M. Omar, "Rare Tumors of Ovary: Case Report and Literature Review," Open Journal of Pathology, Vol. 2 No. 3, 2012, pp. 81-84. doi: 10.4236/ojpathology.2012.23015.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] L. M. Roth, A. Tsubara, M. Dietel and H. Senzaki, “Miscellaneous Tumors and Tumor-Like Conditions of the Ovary,” In: F. A. Tavassoli and P. Devilee, Eds., Pathology and Genetics of Tumors of the Breast and Female Genital Organs, World Health Organization Classification of Tumors, IARC Press, Lyon, 2003, pp. 182-190.
[2] R. J. Collins, A. Cheung, H. Y. Ngan, L. C. Wong, S. Y. Chan and H. K. Ma, “Primary Mixed Neuroendocrine and Mucinous Carcinoma of the Ovary,” Archives of Gynecology and Obstetrics, Vol. 248, No. 3, 1991, pp. 139-143. doi:10.1007/BF02390091
[3] Y. D. Choi, J. S. Lee, C. Choi, C. S. Park and J. H. Nam, “Ovarian Neuroendocrine Carcinoma, Non-Small Cell Type, Associated with Serous Carcinoma,” Gynecologic Oncology, Vol. 104, No. 3, 2007, pp. 747-752. doi:10.1016/j.ygyno.2006.11.008
[4] K. Behnam, D. Kabus and M. Behnam, “Primary Ovarian Undifferentiated Non-Small Cell Carcinoma, Neuroendocrine Type,” Gynecologic Oncology, Vol. 92, No. 1, 2004, pp. 372-375. doi:10.1016/j.ygyno.2003.09.031
[5] P. Dundr, D. Fischerova, C. Povysil and D. Cibula, “Primary Pure Large-Cell Neuroendocrine Carcinoma of the Ovary,” Pathology—Research and Practice, Vol. 204, No. 2, 2008, pp. 133-137. doi:10.1016/j.prp.2007.09.004
[6] C. F.Lindboe, “Large Cell Neuroendocrine Carcinoma of the Ovary,” APMIS, Vol. 115, No. 2, 2007, pp. 169-176. doi:10.1111/j.1600-0463.2007.apm_570.x
[7] K. T. Chen, “Composite Large-Cell Neuroendocrine Carcinoma and Surface Epithelial-Stromal Neoplasm of the Ovary,” International Journal of Surgical Pathology, Vol. 8, No. 2, 2000, pp. 169-174. doi:10.1177/106689690000800214
[8] J. H. Eichhorn, W. D. Lawrence, R. H. Young and R. E. Scully, “Ovarian Neuroendocrine Carcinomas of Non-Small Cell Type Associated with Surface Epithelial Adenocarcinomas. A Study of Five Cases and Review of the Literature,” International Journal of Gynecological Pathology, Vol. 15, 1996, pp. 303-314. doi:10.1097/00004347-199610000-00002
[9] R. J. Collins, A. Cheung, H. Y. Ngan, L. C. Wong, S. Y. Chan and H. K. Ma, “Primary Mixed Neuroendocrine and Mucinous Carcinoma of the Ovary,” Archives of Gynecology and Obstetrics, Vol. 248, No. 3, 1991, pp. 139-143. doi:10.1007/BF02390091
[10] M. Tang, Y. Pires, M. Schultz, I. Duarte, M. Gallegos, I. I. Wistuba, “Microsatellite Analysis of Synchronous and Metachronous Tumors: A Tool for Double Primary Tumor and Metastasis Assessment,” Diagnostic Molecular Pathology, Vol. 12, No. 3, 2003, pp. 151-159. doi:10.1097/00019606-200309000-00006

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.